Diligent Pharma Inc.

About Diligent Pharma Inc.

Diligent Pharma aims to simplify vendor discovery, qualification, and oversight in clinical trials. Their mission is to mitigate risk, increase quality, and shorten trial start-up timelines through a centralized vendor management system, driving innovation in clinical trial quality and compliance.

Products & Services

Diligent360:A centralized platform for sponsors and vendors that streamlines risk-based vendor discovery, qualification, and monitoring.

DiligentRespond:An automated questionnaire tool for vendors that streamlines response management, helping complete forms faster with less effort.

VendorBase:An extensive global database of clinical vendors with robust data on capabilities, experience, qualification, and compliance.

Specialties

Vendor Management Clinical Trial Compliance Risk Mitigation Data-Driven Decision Making Centralized Platform Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 8270000 MR: - FA: 8.27 Million FAN: 8270000	D: 2023-05-15 FD: 2023-05-15	4 investors

Series A Latest

2023-05-15

$8.3M

4 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Patty Leuchten

CEO and Founder

A

Anthea Dransfield

Head of Quality

C

Chris Sallemi

Chief Technology Officer & Head of Innovation Lab

G

Greg Bell

Head of Finance & Administration

D

Dan Lynn

Head of Product Strategy

S

Syed Mujitaba

Director of Product Development

View 5 more team members with Pro

Unlock Full Team Directory

Recent News